X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2042) 2042
Publication (249) 249
Book Review (86) 86
Book Chapter (16) 16
Newspaper Article (11) 11
Conference Proceeding (5) 5
Book / eBook (4) 4
Newsletter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1338) 1338
index medicus (1217) 1217
animals (597) 597
immunology (506) 506
female (505) 505
male (452) 452
long-term (354) 354
medicine, research & experimental (322) 322
immunogenicity (311) 311
vaccination (297) 297
vaccines (276) 276
adult (265) 265
health aspects (260) 260
pharmacology & pharmacy (225) 225
mice (214) 214
efficacy (207) 207
biotechnology & applied microbiology (204) 204
research (204) 204
immunization (203) 203
double-blind (195) 195
adolescent (190) 190
middle aged (187) 187
transplantation (187) 187
care and treatment (183) 183
treatment outcome (179) 179
safety (171) 171
long-term survival (169) 169
analysis (168) 168
child (165) 165
long-term safety (165) 165
antibodies (164) 164
infectious diseases (164) 164
gene therapy (161) 161
children (157) 157
time factors (151) 151
article (145) 145
immunotherapy (142) 142
oncology (139) 139
long-term efficacy (136) 136
aged (135) 135
long-term immunogenicity (134) 134
hepatitis b (130) 130
review (125) 125
clinical trials (124) 124
in-vivo (122) 122
cancer (121) 121
stem cells (119) 119
follow-up (118) 118
immune response (117) 117
hepatitis b - prevention & control (116) 116
infliximab (116) 116
surgery (116) 116
antigens (114) 114
infections (114) 114
gastroenterology & hepatology (113) 113
proteins (111) 111
follow-up studies (109) 109
placebo-controlled trial (109) 109
studies (109) 109
viruses (107) 107
young adult (107) 107
genetics & heredity (106) 106
vaccine (105) 105
genetic vectors (104) 104
long-term treatment (104) 104
medicine & public health (102) 102
t cells (101) 101
child, preschool (100) 100
hepatitis b vaccines - immunology (100) 100
medical research (100) 100
risk factors (100) 100
pediatrics (99) 99
therapy (99) 99
drug therapy (98) 98
medicine (96) 96
allergy and immunology (95) 95
prevention (95) 95
infant (94) 94
genetic therapy - methods (93) 93
infection (92) 92
virology (91) 91
immunity (90) 90
long-term expression (90) 90
antibodies, monoclonal - therapeutic use (88) 88
biochemistry & molecular biology (88) 88
hepatitis b vaccines - administration & dosage (88) 88
disease (87) 87
cell biology (83) 83
rheumatology (82) 82
usage (82) 82
hepatitis b antibodies - blood (81) 81
in-vitro (81) 81
internal medicine (80) 80
gene expression (79) 79
immune system (79) 79
gene transfer techniques (78) 78
hematology (78) 78
microbiology (78) 78
dendritic cells (76) 76
mortality (76) 76
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 08/2014, Volume 10, Issue 8, pp. 2147 - 2162
HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo-controlled study (HPV-001, NCT00689741)... 
human papillomavirus (HPV) | HPV-16/18 AS04-adjuvanted vaccine | safety | long-term protection | cervical cancer | pre-cancer | efficacy | immunogenicity | Immunogenicity | Long-term protection | Efficacy | Human papillomavirus (HPV) | Safety | Pre-cancer | Cervical cancer | HUMAN-PAPILLOMAVIRUS TYPE-16 | OF-STUDY ANALYSIS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | NEUTRALIZATION ASSAY | PARTICLE VACCINE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | INVASIVE CERVICAL-CANCER | BLIND PATRICIA TRIAL | POOLED ANALYSIS | ANTIBODY-RESPONSE | YOUNG-WOMEN | Human papillomavirus 18 - immunology | Follow-Up Studies | Humans | DNA, Viral - analysis | Neutralization Tests | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Young Adult | Human papillomavirus 16 - isolation & purification | Brazil | Papillomavirus Vaccines - adverse effects | Adult | Female | Papillomavirus Vaccines - administration & dosage | Enzyme-Linked Immunosorbent Assay | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Vaginal Smears | Drug-Related Side Effects and Adverse Reactions - epidemiology | Human papillomavirus 18 - isolation & purification | Papillomavirus Infections - prevention & control | Adolescent | Histocytochemistry | Papillomavirus Vaccines - immunology | DNA, Viral - genetics | Antibodies, Neutralizing - blood
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 04/2018, Volume 37, Issue 4, pp. e93 - e102
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 01/2015, Volume 42, Issue 1, pp. 73 - 78
Journal Article
Journal Article
BioDrugs, ISSN 1173-8804, 8/2017, Volume 31, Issue 4, pp. 299 - 316
A systematic review was conducted to explore the immunogenicity of biologic agents across inflammatory diseases and its potential impact on... 
Antibodies | Pharmacotherapy | Cancer Research | Molecular Medicine | Biomedicine | ACTIVE RHEUMATOID-ARTHRITIS | IMMUNOLOGY | DECREASED CLINICAL-RESPONSE | INTRAVENOUS GOLIMUMAB THERAPY | ANTITUMOR NECROSIS FACTOR | ANTI-ADALIMUMAB ANTIBODIES | INFLIXIMAB TROUGH LEVELS | ONCOLOGY | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | METHOTREXATE-NAIVE PATIENTS | LONG-TERM TREATMENT | POST-HOC ANALYSIS | Biosimilar Pharmaceuticals - therapeutic use | Humans | Spondylitis, Ankylosing - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - immunology | Antibodies, Monoclonal - therapeutic use | Infliximab - therapeutic use | Ustekinumab - therapeutic use | Arthritis, Juvenile - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Arthritis, Psoriatic - drug therapy | Crohn Disease - drug therapy | Colitis, Ulcerative - drug therapy | Antibodies, Monoclonal - immunology | Antirheumatic Agents - therapeutic use | Etanercept - therapeutic use | Care and treatment | Usage | Infliximab | Chronic diseases | Dosage and administration | Drug therapy | Adalimumab | Immunoassay | Inflammatory bowel diseases | Medical services | Systematic review | Arthritis | Inflammatory diseases | Proteins | Literature reviews | Infusion | Etanercept | Tumor necrosis factor-TNF | Ankylosing spondylitis | Immunoglobulins | Biological products | Psoriasis | Publications | Dermatology | Decision making | Rheumatology | Rheumatic diseases | Rituximab | Crohn's disease | Tumor necrosis factor-α | Patients | Diseases | Crohns disease | Inflammatory bowel disease | Studies | Spondylitis | Immunogenicity | Rheumatoid arthritis | Monoclonal antibodies | TNF inhibitors | Ulcerative colitis | Systematic Review
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 02/2014, Volume 53, Issue 2, pp. 213 - 222
Journal Article